Oral Lesions of HIV Disease and HAART in Industrialized Countries
Authors:
- 1 April 2006
- journal article
- research article
- Published by SAGE Publications in Advances in Dental Research
- Vol. 19 (1) , 57-62
Abstract
The epidemiology of HIV-related oral disease in industrialized nations has evolved following the initial manifestations described in 1982. Studies from both the Americas and Europe report a decreased frequency of HIV-related oral manifestations of 10–50% following the introduction of HAART (highly active antiretroviral therapy). Evidence suggests that HAART plays an important role in controlling the occurrence of oral candidosis. The effect of HAART on reducing the incidence of oral lesions, other than oral candidosis, does not appear as significant, possibly as a result of low lesion prevalence in industrialized countries. In contrast to other oral manifestations of HIV, an increased prevalence of oral warts in patients on HAART has been reported from the USA and the UK. HIV-related salivary gland disease may show a trend of rising prevalence in the USA and Europe. The re-emergence of HIV-related oral disease may be indicative of failing therapy. A range of orofacial iatrogenic consequences of HAART has been reported, and it is often difficult to distinguish between true HIV-related oral disease manifestations and the adverse effects of HAART. A possible association between an increased risk of oral squamous cell carcinoma and HIV infection has been suggested by at least three epidemiological studies, with reference to the lip and tongue. These substantial and intensive research efforts directed toward enhancing knowledge regarding the orofacial consequences of HIV infection in the industrialized nations require dissemination in the wider health care environment.Keywords
This publication has 100 references indexed in Scilit:
- Oral Candidosis as a Clinical Marker of Immune Failure in Patients with HIV/AIDS on HAARTAIDS Patient Care and STDs, 2005
- Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV‐infected adultsCommunity Dentistry and Oral Epidemiology, 2005
- Human Papillomavirus-Associated Oral Warts among Human Immunodeficiency Virus-Seropositive Patients in the Era of Highly Active Antiretroviral Therapy: An Emerging InfectionClinical Infectious Diseases, 2002
- Antiretroviral Therapy with Protease Inhibitors Has an Early, Immune Reconstitution–Independent Beneficial Effect onCandidaVirulence and Oral Candidiasis in Human Immunodeficiency Virus–Infected SubjectsThe Journal of Infectious Diseases, 2002
- Oral hairy leukoplakia in 71 HIV-seropositive patients: Clinical symptoms, relation to immunologic status, and prognostic significanceJournal of the American Academy of Dermatology, 1996
- Intraoral non-Hodgkin's lymphoma in seven patients with acquired immunodeficiency syndromeOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1996
- Oral conditions and their social impact among HIV dental patientsAustralian Dental Journal, 1996
- Dental care of infectious patients in Denmark, 1986–1993: theoretical considerations and empirical findingsCommunity Dentistry and Oral Epidemiology, 1995
- Replication of Epstein–Barr Virus within the Epithelial Cells of Oral Hairy Leukoplakia, an AIDS-Associated LesionNew England Journal of Medicine, 1985
- Oral Candidiasis in High-Risk Patients as the Initial Manifestation of the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984